DK511383A - Fremgangsmaade til fremstilling af piperidindionderivater, der beskytter hjertemuskulaturen med en antiarythmisk aktivitet - Google Patents

Fremgangsmaade til fremstilling af piperidindionderivater, der beskytter hjertemuskulaturen med en antiarythmisk aktivitet Download PDF

Info

Publication number
DK511383A
DK511383A DK511383A DK511383A DK511383A DK 511383 A DK511383 A DK 511383A DK 511383 A DK511383 A DK 511383A DK 511383 A DK511383 A DK 511383A DK 511383 A DK511383 A DK 511383A
Authority
DK
Denmark
Prior art keywords
derivatives
antiarythmic
indion
piperidine
protecting
Prior art date
Application number
DK511383A
Other languages
English (en)
Other versions
DK511383D0 (da
Inventor
Claude Bernhart
Werner Cautreels
Patrick Gautier
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK511383D0 publication Critical patent/DK511383D0/da
Publication of DK511383A publication Critical patent/DK511383A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK511383A 1982-11-08 1983-11-08 Fremgangsmaade til fremstilling af piperidindionderivater, der beskytter hjertemuskulaturen med en antiarythmisk aktivitet DK511383A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218706A FR2535721A1 (fr) 1982-11-08 1982-11-08 Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives

Publications (2)

Publication Number Publication Date
DK511383D0 DK511383D0 (da) 1983-11-08
DK511383A true DK511383A (da) 1984-05-09

Family

ID=9279000

Family Applications (1)

Application Number Title Priority Date Filing Date
DK511383A DK511383A (da) 1982-11-08 1983-11-08 Fremgangsmaade til fremstilling af piperidindionderivater, der beskytter hjertemuskulaturen med en antiarythmisk aktivitet

Country Status (29)

Country Link
US (1) US4721710A (da)
EP (1) EP0110755B1 (da)
JP (1) JPS59161377A (da)
KR (1) KR900006721B1 (da)
AT (1) ATE22561T1 (da)
AU (1) AU565519B2 (da)
CA (1) CA1221967A (da)
CS (1) CS244681B2 (da)
DD (3) DD229402A5 (da)
DE (1) DE3366623D1 (da)
DK (1) DK511383A (da)
ES (1) ES8406070A1 (da)
FI (1) FI79536C (da)
FR (1) FR2535721A1 (da)
GR (1) GR78747B (da)
HU (1) HU191494B (da)
IE (1) IE56209B1 (da)
IL (1) IL70099A (da)
MA (1) MA19948A1 (da)
NO (1) NO159852C (da)
NZ (1) NZ206177A (da)
OA (1) OA07582A (da)
PH (1) PH20421A (da)
PL (3) PL139946B1 (da)
PT (1) PT77607B (da)
SG (1) SG1989G (da)
SU (3) SU1333237A3 (da)
YU (3) YU221183A (da)
ZA (1) ZA838065B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668689A (en) * 1984-07-19 1987-05-26 National Research Development Corporation Glutarimide derivatives for treating oestrogen-dependent tumors
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE19703763C1 (de) * 1997-02-01 1998-10-01 Gruenenthal Gmbh Thalidomidanaloge Verbindungen aus der Klasse der Piperidin-2,6-Dione
DK2710007T3 (da) 2011-05-17 2020-01-27 Principia Biopharma Inc Kinasehæmmere
AU2012255860C1 (en) 2011-05-17 2015-12-10 Principia Biopharma Inc. Tyrosine kinase inhibitors
WO2012158795A1 (en) 2011-05-17 2012-11-22 Principia Biopharma Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
SMT201900344T1 (it) 2012-09-10 2019-07-11 Principia Biopharma Inc Composti di pirazolopirimidina come inibitori di chinasi
US8957080B2 (en) 2013-04-09 2015-02-17 Principia Biopharma Inc. Tyrosine kinase inhibitors
CN112353806A (zh) 2014-02-21 2021-02-12 普林斯匹亚生物制药公司 Btk抑制剂的盐和固体形式
SG11201704808VA (en) 2014-12-18 2017-07-28 Principia Biopharma Inc Treatment of pemphigus
US20180305350A1 (en) 2015-06-24 2018-10-25 Principia Biopharma Inc. Tyrosine kinase inhibitors
IL263815B (en) 2016-06-29 2022-07-01 Principia Biopharma Inc Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[4,3-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4 -Methyl-4-[4-(Oxtan-3-yl)piperazin-1-yl)pent-2-ananitrile
AU2020365951B2 (en) 2019-10-14 2026-07-16 Principia Biopharma Inc. Methods for treating immune thrombocytopenia by administering (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
KR102993352B1 (ko) 2019-12-20 2026-07-22 프린시피아 바이오파마, 인코퍼레이티드 2-[3-[4-아미노-3-(2-플루오로-4-페녹시-페닐)피라졸로[3,4-d]피리미딘-1-일]피페리딘-1-카르보닐]-4-메틸-4-[4-(옥세탄-3-일)피페라진-1-일]펜트-2-에네니트릴의 고체 형태
WO2021150723A1 (en) 2020-01-22 2021-07-29 Principia Biopharma Inc. Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664424A (en) * 1953-12-29 Dioxo-piperidines
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
CA1221967A (en) 1987-05-19
ES527091A0 (es) 1984-07-01
EP0110755A1 (fr) 1984-06-13
FI79536C (fi) 1990-01-10
GR78747B (da) 1984-10-02
NO159852C (no) 1989-02-15
PT77607B (fr) 1986-03-18
ES8406070A1 (es) 1984-07-01
CS244681B2 (en) 1986-08-14
IE56209B1 (en) 1991-05-22
AU565519B2 (en) 1987-09-17
KR840006641A (ko) 1984-12-01
US4721710A (en) 1988-01-26
OA07582A (fr) 1985-03-31
PH20421A (en) 1987-01-05
ZA838065B (en) 1984-06-27
DD219770A5 (de) 1985-03-13
YU221183A (en) 1986-06-30
SU1333238A3 (ru) 1987-08-23
ATE22561T1 (de) 1986-10-15
PL140992B1 (en) 1987-06-30
AU2089883A (en) 1984-05-17
FR2535721A1 (fr) 1984-05-11
FI834087L (fi) 1984-05-09
YU184185A (en) 1986-06-30
PT77607A (fr) 1983-12-01
HU191494B (en) 1987-02-27
NO159852B (no) 1988-11-07
PL249749A1 (en) 1985-03-12
FI834087A0 (fi) 1983-11-08
NO834057L (no) 1984-05-09
FR2535721B1 (da) 1985-05-17
IL70099A0 (en) 1984-01-31
JPS59161377A (ja) 1984-09-12
SG1989G (en) 1989-06-02
KR900006721B1 (ko) 1990-09-20
DK511383D0 (da) 1983-11-08
SU1333237A3 (ru) 1987-08-23
PL140021B1 (en) 1987-03-31
IL70099A (en) 1987-10-20
YU184285A (en) 1986-06-30
EP0110755B1 (fr) 1986-10-01
PL249750A1 (en) 1985-03-12
PL139946B1 (en) 1987-03-31
IE832581L (en) 1984-05-08
PL244462A1 (en) 1985-02-13
NZ206177A (en) 1985-11-08
SU1316558A3 (ru) 1987-06-07
FI79536B (fi) 1989-09-29
DE3366623D1 (en) 1986-11-06
DD229407A5 (de) 1985-11-06
MA19948A1 (fr) 1984-07-01
DD229402A5 (de) 1985-11-06

Similar Documents

Publication Publication Date Title
DK511383D0 (da) Fremgangsmade til fremstilling af piperidindionderivater,der beskytter hjertemuskulaturen med en antiarythmisk aktivitet
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
AU576888B2 (en) Benzodisultams
DE3674117D1 (de) Verfahren zur herstellung von 1,4-dihydropyridinderivaten ueber neue zwischenprodukte.
GR76976B (da)
DE3270999D1 (de) N-substituted-tetrahydroisophthalimide derivatives
JPS53124277A (en) 1-substed-(1,2-diphenylpropyl)piperazines

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment